LYNX-2: A Pivotal Phase 3 Trial of Phentolamine Ophthalmic Solution in Post-Keratorefractive Surgery Subjects with Decreased Mesopic Visual Acuity
One Year Results from a Phase 1/2 Study of OPGx-LCA5 Subretinal Gene Therapy for the Treatment of LCA5-LCA in Adult Participants
Recovery of Cone-Mediated Vision in Lebercilin-Associated Severe Retinal Ciliopathy (LCA5) after Gene Therapy: One Year Results of a Phase Ib/IIa Trial
LYNX-1 Phase 3 Trial of the Safety and Efficacy of Phentolamine Ophthalmic Solution for the Treatment of Reduced Mesopic Low Contrast Vision: A Subset Analysis of Keratorefractive Subjects
